CX3CR1 IDENTIFIES PD-1 THERAPY-RESPONSIVE CD8+ T CELLS THAT WITHSTAND CHEMOTHERAPY DURING CANCER CHEMOIMMUNOTHERAPY Article Yan Y., Adjei A.A., Mansfield A.S., Markovic S.N., Dronca R.S., Cao S., Liu X., Harrington S.M., Bindeman W.E., Dong H., Jang J.S., Jen J., Li Y., Chanana P., Park S.S. JCI Insight. Vol. 3. 2018.
